Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Michelle Monaghan Discusses Skin Cancer Advocacy and Sun Safety
2
Nurses Create Food Pantry to Fight Food Insecurity Among Pediatric Cancer Families
3
Why Cancer Survivors Should Celebrate Every Cancer-Free Anniversary
4
Nursing Leader Drives Equity in Kidney Cancer Clinical Trials
5